Liberia travel health
Sources checked
Overview
Liberia has year‑round tropical infectious‑disease risks (notably malaria and Lassa fever), routine immunization gaps in some areas, and variable access to emergency and specialist care outside Monrovia. Preparation should prioritise required travel certificates, malaria prevention, up‑to‑date routine vaccines, and a plan for medical evacuation or referral if you need advanced care.
Health system and access to care
Medical facilities and emergency services are limited in much of the country; serious illness may require referral abroad or medevac. Carry travel health insurance that covers evacuation and confirm availability of any specialty medicines you need. U.S. Department of State and the UK Foreign Office provide practical details on health services and evacuation considerations.
Vaccinations and entry requirements
This section separates legal/administrative entry requirements from vaccines commonly recommended for travellers; discuss individual needs with a travel‑health clinician.
Yellow fever — certificate and vaccine
Liberia enforces yellow‑fever controls consistent with International Health Regulations: travellers may be required to show an International Certificate of Vaccination (yellow card) when arriving from countries with yellow‑fever risk, and the Ministry of Health provides vaccination and issues the yellow card at major ports of entry. Decide on vaccination before travel if you meet CDC/WHO age and medical eligibility criteria. Ministry of Health (Liberia), Centers for Disease Control and Prevention (CDC).
Routine and commonly recommended vaccines
Ensure routine immunizations (MMR, diphtheria‑tetanus‑pertussis, polio, varicella, influenza) are up to date. For travel to Liberia, health authorities widely recommend Hepatitis A and Hepatitis B vaccines for unvaccinated travellers; typhoid vaccine is recommended for most travellers; rabies pre‑exposure vaccination should be considered for people at increased risk of animal exposure or where prompt post‑exposure treatment may be unavailable. For country‑specific vaccine guidance and target groups, see the CDC traveller guidance. Centers for Disease Control and Prevention (Liberia travel page).
COVID‑19, measles and other routine precautions
Follow current COVID‑19 vaccination recommendations for eligible travellers and make sure you are protected against measles before international travel. Measles activity occurs worldwide; international travellers should be fully immunized. CDC – Liberia travel health.
Other health risks
Non‑vaccine risks that commonly affect visitors or require specific prevention are described below. Advice varies with itinerary, season, accommodation and activities.
Malaria
Malaria transmission is present throughout Liberia year‑round, and Plasmodium falciparum is the dominant species. CDC recommends that all travellers to Liberia take antimalarial chemoprophylaxis; choices include atovaquone‑proguanil, doxycycline, mefloquine or tafenoquine depending on medical history and timing. In addition use insect‑bite prevention (LLINs, repellents with DEET or picaridin, clothing). CDC, WHO malaria country profile (Liberia).
Lassa fever (endemic)
Lassa fever is endemic in Liberia and cases are reported periodically. Transmission to humans is typically from infected rodents or close contact with infected people; risk is higher in rural or poorly‑resourced healthcare settings. Travellers should avoid contact with rodents and follow strict infection‑prevention steps if visiting patients or working in healthcare/laboratory settings. Seek immediate medical care for febrile illness after exposure. WHO Regional Office for Africa (Lassa fever), CDC (Lassa fever).
Mpox (recent activity)
Liberia experienced sustained mpox transmission during 2024–2026 with national response activities including case finding and targeted vaccination campaigns; travellers who plan close intimate or household contact in affected areas should consider vaccination and risk‑reduction practices. Check current local situation before travel. Ministry of Health (Liberia), WHO mpox external situation report, UNICEF – Liberia.
Dengue and other arboviruses
Dengue virus transmission has been documented in Liberia and neighbouring countries; severe dengue is uncommon but possible. Mosquito‑bite prevention is the primary protection (repellents, clothing, screens). A recent laboratory‑confirmed fatal dengue case underscores the importance of early care for febrile illness. Peer‑reviewed report of dengue in Liberia (PubMed), CDC.
Water, food and diarrhoeal illness (including cholera)
Limited water, sanitation and hygiene infrastructure in parts of Liberia increases the risk of travellers acquiring diarrhoeal diseases including cholera during local outbreaks. Practice safe food and water precautions, and seek rapid care for moderate–severe dehydration. Local and WHO surveillance reports note sporadic cholera and acute watery diarrhoea activity in recent years. WHO – Liberia annual report 2025, CDC.
Current health alerts
Only alerts with confirmed, country‑level evidence are listed; check the linked authorities for daily updates before departure.
Mpox: national response and vaccination
National authorities reported sustained mpox transmission through 2025–2026 and have mounted case‑finding, vaccination and support programmes; Liberia’s Ministry of Health continued targeted vaccination and social support measures into 2026. Travellers planning intimate or household contact should assess vaccination and exposure risk. Ministry of Health (Liberia), WHO situation report, World Food Programme.
Lassa fever: endemic presence and surveillance
Lassa fever remains endemic in Liberia with periodic confirmed cases; public‑health authorities continue surveillance and preparedness. Travellers with rural exposure, health‑care work, or rodent contact should observe strict rodent‑avoidance and hygiene measures and seek immediate care for febrile illness. WHO Regional Office for Africa (Lassa), WHO Liberia annual report 2025.
Ebola and other viral haemorrhagic fevers
As of the sources listed here, Liberia had no confirmed Ebola cases but public health authorities maintain heightened border and airport surveillance in response to regional Ebola outbreaks. If you develop fever after travel, tell clinicians about travel and possible exposure to viral haemorrhagic fever. Government of Liberia press release (MOH/NPHIL), WHO – DRC Ebola situation.
Before you travel
Plan at least 4–6 weeks before travel when possible to allow vaccination and preventive medicines to take effect and to obtain documentation.
Key preparations
Visit a travel‑health clinician to review required entry certificates (yellow fever), start malaria chemoprophylaxis as advised, update routine and destination vaccines (Hep A, Hep B, typhoid, MMR), and consider rabies pre‑exposure vaccination for high‑risk travellers. Pack insect repellent, water‑treatment options, a basic first‑aid kit and any regular prescriptions. Enrol in your government traveller registry and buy evacuation insurance if you may need specialised care. CDC – Liberia travel guidance, U.S. Department of State.
Final note
This information summarizes published public‑health guidance. A travel‑health professional can advise on your itinerary, medical history and vaccination needs.
